Home >> Research Area >>Natural Products>>Lignans>> (-)-Syringaresinol

(-)-Syringaresinol

CAS# 6216-81-5

(-)-Syringaresinol

Catalog No. BCN3417----Order now to get a substantial discount!

Product Name & Size Price Stock
(-)-Syringaresinol: 5mg $161 In Stock
(-)-Syringaresinol: 10mg Please Inquire In Stock
(-)-Syringaresinol: 20mg Please Inquire Please Inquire
(-)-Syringaresinol: 50mg Please Inquire Please Inquire
(-)-Syringaresinol: 100mg Please Inquire Please Inquire
(-)-Syringaresinol: 200mg Please Inquire Please Inquire
(-)-Syringaresinol: 500mg Please Inquire Please Inquire
(-)-Syringaresinol: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of (-)-Syringaresinol

Number of papers citing our products

Chemical structure

(-)-Syringaresinol

3D structure

Chemical Properties of (-)-Syringaresinol

Cas No. 6216-81-5 SDF Download SDF
PubChem ID 11604108 Appearance Powder
Formula C22H26O8 M.Wt 418.4
Type of Compound Lignans Storage Desiccate at -20°C
Solubility Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Chemical Name 4-[(3R,3aS,6R,6aS)-6-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2,6-dimethoxyphenol
SMILES COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)O)OC
Standard InChIKey KOWMJRJXZMEZLD-WRMVBYCNSA-N
Standard InChI InChI=1S/C22H26O8/c1-25-15-5-11(6-16(26-2)19(15)23)21-13-9-30-22(14(13)10-29-21)12-7-17(27-3)20(24)18(8-12)28-4/h5-8,13-14,21-24H,9-10H2,1-4H3/t13-,14-,21+,22+/m1/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of (-)-Syringaresinol

The rhizomes of Polygonatum kingianum

Biological Activity of (-)-Syringaresinol

Description1. (-)-Syringaresinol inhibits the proliferation of human promyelocytic HL-60 cells through G(1) arrest and induction of apoptosis, may be a potential chemotherapeutic agent for the treatment of cancer.
TargetsCdk | p21 | Bcl-2/Bax | Caspase | PARP | P450 (e.g. CYP17)

(-)-Syringaresinol Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

(-)-Syringaresinol Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of (-)-Syringaresinol

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.3901 mL 11.9503 mL 23.9006 mL 47.8011 mL 59.7514 mL
5 mM 0.478 mL 2.3901 mL 4.7801 mL 9.5602 mL 11.9503 mL
10 mM 0.239 mL 1.195 mL 2.3901 mL 4.7801 mL 5.9751 mL
50 mM 0.0478 mL 0.239 mL 0.478 mL 0.956 mL 1.195 mL
100 mM 0.0239 mL 0.1195 mL 0.239 mL 0.478 mL 0.5975 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on (-)-Syringaresinol

(-)-Syringaresinol inhibits proliferation of human promyelocytic HL-60 leukemia cells via G1 arrest and apoptosis.[Pubmed:18486907]

Int Immunopharmacol. 2008 Jul;8(7):967-73.

We examined the effect of (-)-Syringaresinol, a furofuran-type lignan isolated from Daphne genkwa, on cell cycle regulation in HL-60 human promyelocytic leukemia cells in vitro. (-)-Syringaresinol decreased the viability of HL-60 cells by inducing G(1) arrest followed by apoptosis in a dose- and time-dependent manner. The G(0)/G(1) phase of the cell cycle is regulated by cyclin-dependent kinases (Cdk), cyclins and cyclin-dependent kinase inhibitors (Cdki). We show by western blot analysis, that the (-)-Syringaresinol-induced G(1) arrest was mediated through the increased expression of Cdki proteins (p21(cip1/waf1) and p27(kip1)) with a simultaneous decrease in cdk2, cdk4, cdk6, cyclin D(1), cyclin D(2), and cyclin E expression. The induction of apoptosis after treatment with (-)-Syringaresinol for 24 h was demonstrated by morphological changes, DNA fragmentation, altered ratio of Bax/Bcl-2, cleavage of poly(ADP-ribose) polymerase and flow cytometry analysis. (-)-Syringaresinol also induced cytochrome c release and activation of caspase-3 and caspase-9. To our knowledge, this is the first time that (-)-Syringaresinol has been reported to potently inhibit the proliferation of human promyelocytic HL-60 cells through G(1) arrest and induction of apoptosis. These findings suggest that (-)-Syringaresinol may be a potential chemotherapeutic agent for the treatment of cancer.

Keywords:

(-)-Syringaresinol,6216-81-5,Natural Products, buy (-)-Syringaresinol , (-)-Syringaresinol supplier , purchase (-)-Syringaresinol , (-)-Syringaresinol cost , (-)-Syringaresinol manufacturer , order (-)-Syringaresinol , high purity (-)-Syringaresinol

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: